On November 18, Molina Healthcare fell 4.66% in Regular Trading, trading at $210.5 per share, with turnover of $9.1141 million.
The move aligns with renewed weakness across managed care after US regulators proposed a new rule targeting fraud, waste, and abuse across Medicare, Medicaid, and marketplace plans.
The proposal is expected to save nearly $90 billion over 10 years and includes more frequent Medicare Advantage audits, stronger enrollment safeguards, and tighter scrutiny of deductions from Medicaid payments. The sector reaction was broadly negative, with UnitedHealth falling 4.24%, Humana falling 6.1%, Elevance Health falling 3.46%, and Centene falling 4.77%. Molina Healthcare had risen a day earlier on a temporary easing of Medicaid work-rule enforcement, but the latest regulatory overhang appears to have outweighed that earlier relief.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments